{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Morristown",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA021116"
        ],
        "brand_name": [
          "LEVOTHYROXINE SODIUM"
        ],
        "generic_name": [
          "LEVOTHYROXINE SODIUM"
        ],
        "manufacturer_name": [
          "Alvogen, Inc."
        ],
        "product_ndc": [
          "47781-640",
          "47781-643",
          "47781-646",
          "47781-649",
          "47781-651",
          "47781-654",
          "47781-657",
          "47781-659",
          "47781-662",
          "47781-665",
          "47781-668",
          "47781-671"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "LEVOTHYROXINE SODIUM"
        ],
        "rxcui": [
          "892246",
          "892251",
          "892255",
          "966220",
          "966221",
          "966222",
          "966224",
          "966225",
          "966248",
          "966249",
          "966253",
          "966270"
        ],
        "spl_id": [
          "12e236b4-dc71-96ce-cdd3-7bede41b3f1c"
        ],
        "spl_set_id": [
          "4ddcaec1-a58f-340b-9bc1-bbe048b8c885"
        ],
        "package_ndc": [
          "47781-640-90",
          "47781-640-10",
          "47781-643-90",
          "47781-643-10",
          "47781-646-90",
          "47781-646-10",
          "47781-649-90",
          "47781-649-10",
          "47781-651-90",
          "47781-651-10",
          "47781-654-90",
          "47781-654-10",
          "47781-657-90",
          "47781-657-10",
          "47781-659-90",
          "47781-659-10",
          "47781-662-90",
          "47781-662-10",
          "47781-665-90",
          "47781-665-10",
          "47781-668-90",
          "47781-668-10",
          "47781-671-90",
          "47781-671-10"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0347781649906",
          "0347781671907",
          "0347781643904",
          "0347781657901",
          "0347781640903",
          "0347781651909",
          "0347781662905",
          "0347781665906",
          "0347781646905",
          "0347781654900",
          "0347781659905"
        ],
        "unii": [
          "9J765S329G"
        ]
      },
      "product_type": "Drugs",
      "event_id": "98225",
      "recalling_firm": "Alvogen, Inc",
      "address_1": "44 Whippany Rd Ste 300",
      "address_2": "",
      "postal_code": "07960-4558",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide.",
      "recall_number": "D-0259-2026",
      "product_description": "Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.",
      "product_quantity": "",
      "reason_for_recall": "Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.",
      "recall_initiation_date": "20251231",
      "center_classification_date": "20260114",
      "report_date": "20260121",
      "code_info": "Lot # MHA21825, Exp Date: December 31, 2027",
      "more_code_info": ""
    }
  ]
}